AJCN Tufts Nutrition Symposium, Boston & Online Sept 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giovannucci, E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Giovannucci, E.
Agricola
Right arrow Articles by Giovannucci, E.
American Journal of Clinical Nutrition, Vol. 86, No. 3, 836S-842S, September 2007
© 2007 American Society for Nutrition


Metabolic Syndrome and the Onset of Cancer

Metabolic syndrome, hyperinsulinemia, and colon cancer: a review1,2,3

Edward Giovannucci

1 From the Departments of Epidemiology and Nutrition, Harvard School of Public Health, and the Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

ABSTRACT

An impressive body of epidemiologic data collected over the past decade indicates that the risk of colon cancer is elevated in those with metabolic syndrome. This evidence includes studies that examined the risk of colon cancer or adenoma in relation to determinants of the metabolic syndrome (obesity, abdominal distribution of adiposity, and physical inactivity), clinical consequences of this syndrome (type 2 diabetes and hypertension), plasma or serum components of the definition of metabolic syndrome (hypertriglyceridemia, hyperglycemia, and low HDL cholesterol), and markers of hyperinsulinemia or insulin resistance (insulin and C-peptide), which is the underlying metabolic defect of the metabolic syndrome. The mechanism underlying these associations is unknown but may involve the influence of hyperinsulinemia in enhancing free or bioavailable concentrations of insulin-like growth factor-1. Future studies should also be based on better measurements of insulin resistance, ß-cell depletion, and insulin responses to better assess which aspects of insulin resistance are most closely related to the risk of colon neoplasia.

Key Words: Obesity • exercise • epidemiology • insulin • metabolic syndrome • colon cancer




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
J.-R. Zhou, G. L Blackburn, and W A. Walker
Symposium introduction: metabolic syndrome and the onset of cancer
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 817S - 819S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition